glp-1 agonist drug interactions Interactions: Hidden Risks Table 2 from Optimizing Outcomes

Until the data of the SURPASS-CVOT trial are available, tirzepatide will most likely have a place in the algorithm of T2D therapy for patients with obesity and T2D that have the therapeutic aim to normalize glycemia and decrease body weight

Effects of semaglutide on muscle structure and function in the SLIM LIVER study

Comparative analysis of outcomes between those who used GLP-1 RAs in the first 3 months post-transplant and continued from 3 to 6 months, versus those who did not use GLP-1 RAs during either period, yielded similar results (Supplemental Table 9)

How do GLP-1 medications help with weight loss

Common side effects include nausea, vomiting, diarrhea, constipation and abdominal pain, as well as headache and dizziness

Cardiovascular Benefits : Research suggests Ozempic may reduce the risk of heart attacks, strokes, and other cardiovascular events, particularly in those with diabetes